Sevelamer Carbonate Powder, For Suspension
Product Images NDC 0115-1366

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 0115-1366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

We (Sevelamer Carbonate For Oral Suspension 0 8 Gm And 1)

Chemical structure diagram of sevelamer carbonate, showing the polymeric amine backbone with associated ammonium groups and carbonate ions.*

FDA Label Image

Sevelamer Carbonate For Oral Suspension 0 8 Gm And 10

Packaging label for Sevelamer Carbonate For Oral Suspension, 2.4 g packets, lemon flavor. The label indicates it contains 90 packets and is for oral use. The active ingredient is sevelamer carbonate 2.4 g per packet. The product is manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC. The label includes usage directions and storage instructions, with branding by Amneal Pharmaceuticals of New York LLC.*

FDA Label Image

2 (Sevelamer Carbonate For Oral Suspension 0 8 Gm And 2)

A forest plot chart showing the least squares mean difference between Sevelamer Carbonate and placebo across several subgroups, including screening body surface area, baseline serum phosphorus levels, age, and dialysis status. The x-axis represents the mean difference ranging from -5 to 5, with markers indicating individual subgroup results and confidence intervals. The chart includes a note explaining the statistical method using ANCOVA with treatment as a fixed effect and screening BSA and baseline serum phosphorus as covariates.*

FDA Label Image

Qt (Sevelamer Carbonate For Oral Suspension 0 8 Gm And 3)

A line graph showing the percentage of patients with reduction in serum phosphorus levels. The x-axis represents reduction in serum phosphorus (mg/dL) ranging from -4 to 8, and the y-axis shows the percentage of patients with reduction 2x from 0 to 100%. Two treatment groups are plotted: Sevelamer Hydrochloride and Active Control, with annotations indicating movement from worsened increase to improved reduction in serum phosphorus.*

FDA Label Image

Gh (Sevelamer Carbonate For Oral Suspension 0 8 Gm And 4)

A line graph comparing the change from baseline of phosphorus levels over 52 study weeks. The graph displays data for two treatments: Sevelamer Hydrochloride and Active-Control, showing phosphorus change on the vertical axis and study weeks on the horizontal axis.*

FDA Label Image

0.8 G (Sevelamer Carbonate For Oral Suspension 0 8 Gm And 5)

Sevelamer Carbonate For Oral Suspension 0.8 g powder packet with lemon flavor. The label indicates it is for oral use, contains one packet, and is a prescription-only medication. The packaging is branded by Amneal Pharmaceuticals of New York LLC and features an orange and white design.*

FDA Label Image

Fg (Sevelamer Carbonate For Oral Suspension 0 8 Gm And 6)

Drug information panel for sevelamer carbonate powder for suspension 800 mg per packet, including directions to empty the packet into at least 1 ounce (2 tablespoons) of water, stir well, and drink within 30 minutes. Storage instructions specify temperature ranges and protection from moisture. Manufacturer is Amneal Pharmaceuticals Pvt. Ltd., India, with distribution by Amneal Pharmaceuticals LLC, NJ. Lot and expiration space indicated below a barcode.*

FDA Label Image

2.4 G (Sevelamer Carbonate For Oral Suspension 0 8 Gm And 7)

Packaging label for Sevelamer Carbonate For Oral Suspension 0.8 g packets, lemon flavor. The label states it contains 90 packets and is for Rx only. It is manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC. Directions and ingredients are printed on the label alongside branding and dosage information.*

FDA Label Image

Cb (Sevelamer Carbonate For Oral Suspension 0 8 Gm And 8)

Sevelamer Carbonate For Oral Suspension 2.4 g powder packet in lemon flavor. The label displays a single packet with the NDC 0115-1366-30, indicates prescription use only, and is labeled by Amneal Pharmaceuticals of New York LLC.*

FDA Label Image

Sevelamer Carbonate For Oral Suspension 0 8 Gm And 9

Drug facts and usage instructions for sevelamer carbonate powder for suspension. It states each packet contains 2.4 grams of sevelamer carbonate, with directions to empty the packet into at least 2 ounces (4 tablespoons) of water, stir well, and drink within 30 minutes. Storage instructions and manufacturer details for Amneal Pharmaceuticals are also included, along with a barcode and space for lot and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.